Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Parkinson's Disease

Free Subscription Articles published in Brain Res Retrieve available abstracts of 56 articles: HTML format

Single Articles

April 2021
1. GAN C, Ma K, Wang L, Si Q, et al
   Dynamic functional connectivity changes in Parkinson's disease patients with REM sleep behavior disorder.
   Brain Res. 2021 Apr 11:147477. doi: 10.1016/j.brainres.2021.147477.
   PubMed     Abstract available
   
   
   March 2021
2. SUBRAHMANIAN N, LaVoie MJ
   Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal.
   Brain Res. 2021 Mar 18:147434. doi: 10.1016/j.brainres.2021.147434.
   PubMed     Abstract available
   
   
   
3. FERNANDEZ-ESPEJO E, Rodriguez de Fonseca F, Suarez J, Martin de Pablos A, et al
   Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson's disease, and correlates with levodopa equivalent daily dose.
   Brain Res. 2021 Mar 4:147411. doi: 10.1016/j.brainres.2021.147411.
   PubMed     Abstract available
   
   
   January 2021
4. VEDAM-MAI V
   Harnessing The Immune System For The Treatment Of Parkinson's Disease.
   Brain Res. 2021 Jan 29:147308. doi: 10.1016/j.brainres.2021.147308.
   PubMed     Abstract available
   
   
   
5. LIU J, Hu H, Wu B
   RIPK1 inhibitor ameliorates the MPP(+)/MPTP-induced Parkinson's disease through the ASK1/JNK signalling pathway.
   Brain Res. 2021 Jan 29:147310. doi: 10.1016/j.brainres.2021.147310.
   PubMed     Abstract available
   
   
   
6. WANG Y, Yao L, Gao S, Zhang G, et al
   Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson's disease.
   Brain Res. 2021 Jan 7:147266. doi: 10.1016/j.brainres.2020.147266.
   PubMed     Abstract available
   
   
   
7. CRIAUD M, Kim JH, Zurowski M, Lobaugh N, et al
   Anxiety in Parkinson's Disease: Abnormal resting activity and connectivity.
   Brain Res. 2021 Jan 4:147235. doi: 10.1016/j.brainres.2020.147235.
   PubMed     Abstract available
   
   
   November 2020
8. FERRAZ CRUZ C, Maria Forti Barela A, Dona F, Gracioli Genoves G, et al
   Parkinson's disease delays predictable visual cue processing without affecting complex and unpredictable visual cue processing in postural control.
   Brain Res. 2020 Nov 25:147209. doi: 10.1016/j.brainres.2020.147209.
   PubMed     Abstract available
   
   
   September 2020
9. TOCZYLOWSKA B, Zieminska E, Michalowska M, Chalimoniuk M, et al
   Changes in the metabolic profiles of the serum and putamen in Parkinson's disease patients - in vitro and in vivo NMR spectroscopy studies.
   Brain Res. 2020 Sep 12:147118. doi: 10.1016/j.brainres.2020.147118.
   PubMed     Abstract available
   
   
   
10. STEMICK J, Gauer C, Wihan J, Moceri S, et al
    Compensatory neuritogenesis of serotonergic afferents within the striatum of a transgenic rat model of Parkinson's disease.
    Brain Res. 2020 Sep 10:147119. doi: 10.1016/j.brainres.2020.147119.
    PubMed     Abstract available
    
    
    April 2020
11. HE H, Liang L, Tang T, Luo J, et al
    Progressive Brain Changes in Parkinson's Disease: A Meta-Analysis of Structural Magnetic Resonance Imaging Studies.
    Brain Res. 2020 Apr 21:146847. doi: 10.1016/j.brainres.2020.146847.
    PubMed     Abstract available
    
    
    March 2020
12. ANDERSON C, Sheppard D, Dorval AD
    Parkinsonism and subthalamic deep brain stimulation dysregulate behavioral motivation in a rodent model.
    Brain Res. 2020 Mar 11:146776. doi: 10.1016/j.brainres.2020.146776.
    PubMed    
    
    
    January 2020
13. BOROS FA, Maszlag-Torok R, Vecsei L, Klivenyi P, et al
    Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson's disease.
    Brain Res. 2020;1730:146672.
    PubMed     Abstract available
    
    
    
14. LEE S, Lee Y, Ha S, Chung HY, et al
    Anti-inflammatory effects of usnic acid in an MPTP-induced mouse model of Parkinson's disease.
    Brain Res. 2020 Jan 10:146642. doi: 10.1016/j.brainres.2019.146642.
    PubMed     Abstract available
    
    
    November 2019
15. BROWN DR, Richardson SP, Cavanagh JF
    An EEG marker of reward processing is diminished in Parkinson's disease.
    Brain Res. 2019 Nov 5:146541. doi: 10.1016/j.brainres.2019.146541.
    PubMed     Abstract available
    
    
    
16. BINDA KH, Real CC, Ferreira AFF, Britto LRG, et al
    Antinociceptive effects of treadmill exercise in a rat model of Parkinson's disease: the role of cannabinoid and opioid receptors.
    Brain Res. 2019 Nov 4:146521. doi: 10.1016/j.brainres.2019.146521.
    PubMed     Abstract available
    
    
    October 2019
17. HILL AT, McModie S, Fung W, Hoy KE, et al
    Impact of Prefrontal Intermittent Theta-Burst Stimulation on Working Memory and Executive Function in Parkinson's Disease: A Double-Blind Sham-Controlled Pilot Study.
    Brain Res. 2019 Oct 18:146506. doi: 10.1016/j.brainres.2019.146506.
    PubMed     Abstract available
    
    
    
18. ZHU J, Gao W, Shan X, Wang C, et al
    Apelin-36 Mediates Neuroprotective Effects by Regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's Disease model mice.
    Brain Res. 2019 Oct 3:146493. doi: 10.1016/j.brainres.2019.146493.
    PubMed     Abstract available
    
    
    September 2019
19. AGOSTA S, Magnago D, Galante E, Ferraro F, et al
    Lateralized cognitive functions in Parkinson's patients: a behavioral approach for the early detection of sustained attention deficits.
    Brain Res. 2019 Sep 30:146486. doi: 10.1016/j.brainres.2019.146486.
    PubMed     Abstract available
    
    
    
20. NADEAU J, Smith T, Lamontagne-Proulx J, Bourque M, et al
    Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor.
    Brain Res. 2019 Sep 13:146460. doi: 10.1016/j.brainres.2019.146460.
    PubMed     Abstract available
    
    
    
21. CAVELLI M, Prunell G, Costa G, Velasquez N, et al
    Electrocortical high frequency activity and respiratory entrainment in 6-hydroxydopamine model of Parkinson's disease.
    Brain Res. 2019 Sep 6:146439. doi: 10.1016/j.brainres.2019.146439.
    PubMed     Abstract available
    
    
    July 2019
22. KIM J, Daadi MM
    Non-Cell Autonomous Mechanism of Parkinson's Disease Pathology Caused by G2019S LRRK2 Mutation in Ashkenazi Jewish Patient: Single Cell Analysis.
    Brain Res. 2019 Jul 19:146342. doi: 10.1016/j.brainres.2019.146342.
    PubMed     Abstract available
    
    
    
23. JIANG Y, Liu J, Chen L, Jin Y, et al
    Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson's disease.
    Brain Res. 2019 Jul 10:146331. doi: 10.1016/j.brainres.2019.146331.
    PubMed     Abstract available
    
    
    June 2019
24. LAI JH, Chen KY, Chung-Che Wu J, Olson L, et al
    Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.
    Brain Res. 2019 Jun 18:146301. doi: 10.1016/j.brainres.2019.146301.
    PubMed     Abstract available
    
    
    April 2019
25. JIANG X, Yan Y, Wang K, Wei J, et al
    Brain State-dependent Alterations of Corticostriatal Synchronized Oscillations in Awake and Anesthetized Parkinsonian Rats.
    Brain Res. 2019 Apr 23. pii: S0006-8993(19)30220.
    PubMed     Abstract available
    
    
    March 2019
26. ZHU J, Dou S, Jiang Y, Chen J, et al
    Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
    Brain Res. 2019 Mar 23. pii: S0006-8993(19)30166.
    PubMed     Abstract available
    
    
    January 2019
27. SINGH A, Zhi L, Zhang H
    LRRK2 and mitochondria: Recent advances and current views.
    Brain Res. 2019;1702:96-104.
    PubMed     Abstract available
    
    
    
28. DUNN AR, Hoffman CA, Stout KA, Ozawa M, et al
    Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain.
    Brain Res. 2019;1702:85-95.
    PubMed     Abstract available
    
    
    
29. GOLDSTEIN DS, Sharabi Y
    The heart of PD: Lewy body diseases as neurocardiologic disorders.
    Brain Res. 2019;1702:74-84.
    PubMed     Abstract available
    
    
    November 2018
30. LIU XG, Lu S, Liu DQ, Zhang L, et al
    ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson's and Huntington's diseases.
    Brain Res. 2018 Nov 24. pii: S0006-8993(18)30600.
    PubMed     Abstract available
    
    
    October 2018
31. CAI X, Qiao J, Knox T, Iriah S, et al
    In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
    Brain Res. 2018 Oct 30. pii: S0006-8993(18)30551.
    PubMed     Abstract available
    
    
    
32. RAHMANI F, Saghazadeh A, Rahmani M, Teixeira AL, et al
    Plasma Levels of Brain-Derived Neurotrophic Factor in Patients with Parkinson Disease: A Systematic Review and Meta-Analysis.
    Brain Res. 2018 Oct 5. pii: S0006-8993(18)30510.
    PubMed     Abstract available
    
    
    September 2018
33. LEE Y, Cho JH, Lee S, Lee W, et al
    Neuroprotective effects of MHY908, a PPAR alpha/gamma dual agonist, in a MPTP-induced Parkinson's disease model.
    Brain Res. 2018 Sep 28. pii: S0006-8993(18)30501.
    PubMed     Abstract available
    
    
    July 2018
34. MAMAIS A, Manzoni C, Nazish I, Arber C, et al
    Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology.
    Brain Res. 2018 Jul 25. pii: S0006-8993(18)30407.
    PubMed     Abstract available
    
    
    May 2018
35. LEI J, Conradi N, Abel C, Frisch S, et al
    Cognitive effects of rhythmic auditory stimulation in Parkinson's disease: A P300 study.
    Brain Res. 2018 May 16. pii: S0006-8993(18)30262.
    PubMed     Abstract available
    
    
    March 2018
36. MARSHALL C, King KM, Kortagere S
    Limitations of the rat medial forebrain lesion model to study prefrontal cortex mediated cognitive tasks in Parkinson's Disease.
    Brain Res. 2018 Mar 30. pii: S0006-8993(18)30178.
    PubMed     Abstract available
    
    
    
37. KLAVER AC, Coffey MP, Aasly JO, Loeffler DA, et al
    CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutations.
    Brain Res. 2018;1683:12-16.
    PubMed     Abstract available
    
    
    February 2018
38. YANG X, Zhu Z, Ding X, Wang X, et al
    CaMKII inhibition ameliorated levodopa-induced dyskinesia by downregulating tyrosine hydroxylase activity in an experimental model of Parkinson's disease.
    Brain Res. 2018 Feb 14. pii: S0006-8993(18)30071.
    PubMed     Abstract available
    
    
    
39. HONJO Y, Ayaki T, Horibe T, Ito H, et al
    FKBP12-immunopositive inclusions in patients with alpha-synucleinopathies.
    Brain Res. 2018;1680:39-45.
    PubMed     Abstract available
    
    
    January 2018
40. LIDDLE RA
    Parkinson's Disease from the Gut.
    Brain Res. 2018 Jan 19. pii: S0006-8993(18)30018.
    PubMed     Abstract available
    
    
    December 2017
41. KELM-NELSON CA, Brauer AFL, Barth KJ, Lake JM, et al
    Characterization of early-onset motor deficits in the Pink1 -/- mouse model of Parkinson disease.
    Brain Res. 2017 Dec 8. pii: S0006-8993(17)30536.
    PubMed     Abstract available
    
    
    November 2017
42. LIN D, Liang Y, Jing X, Chen Y, et al
    Microarray analysis of an synthetic alpha-synuclein induced cellular model reveals the expression profile of long non-coding RNA in Parkinson's disease.
    Brain Res. 2017 Nov 11. pii: S0006-8993(17)30502.
    PubMed     Abstract available
    
    
    October 2017
43. ZHANG R, Andersen AH, Hardy PA, Forman E, et al
    Objectively measuring effects of electro-acupuncture in parkinsonian rhesus monkeys.
    Brain Res. 2017 Oct 7. pii: S0006-8993(17)30446.
    PubMed     Abstract available
    
    
    September 2017
44. WILLIS GL, Freelance CB
    A Historical Review on the Emerging Preclinical Interest Concerning the Role of Circadian Function in Parkinson's disease.
    Brain Res. 2017 Sep 25. pii: S0006-8993(17)30424.
    PubMed     Abstract available
    
    
    July 2017
45. LI M, Li L, Wang K, Su W, et al
    The effect of electroacupuncture on proteomic changes in the motor cortex of 6-OHDA Parkinsonian rats.
    Brain Res. 2017 Jul 28. pii: S0006-8993(17)30326.
    PubMed     Abstract available
    
    
    May 2017
46. HOPFNER F, Kunstner A, Muller SH, Kunzel S, et al
    Gut Microbiota in Parkinson Disease in a northern German cohort.
    Brain Res. 2017 May 12. pii: S0006-8993(17)30180.
    PubMed     Abstract available
    
    
    March 2017
47. CAUQUIL AS, Ory-Magne F, Jardine V, Galitzky M, et al
    Parkinson's patients can rely on perspective cues to perceive 3D space.
    Brain Res. 2017 Mar 18. pii: S0006-8993(17)30125.
    PubMed     Abstract available
    
    
    
48. LEE Y, Heo G, Lee KM, Kim AH, et al
    Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
    Brain Res. 2017 Mar 17. pii: S0006-8993(17)30133.
    PubMed     Abstract available
    
    
    February 2017
49. BALUCHNEJADMOJARAD T, Rabiee N, Zabihnejad S, Roghani M, et al
    Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERbeta/Nrf2/HO-1 signaling.
    Brain Res. 2017 Feb 23. pii: S0006-8993(17)30092.
    PubMed     Abstract available
    
    
    December 2016
50. QUINTERO-ESPINOSA D, Jimenez-Del-Rio M, Velez-Pardo C
    Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson's disease.
    Brain Res. 2016 Dec 29. pii: S0006-8993(16)30844.
    PubMed     Abstract available
    
    
    
51. FALQUETTO B, Tuppy M, Potje SR, Moreira TS, et al
    Cardiovascular dysfunction associated with neurodegeneration in an experimental model of parkinson's disease.
    Brain Res. 2016 Dec 9. pii: S0006-8993(16)30819.
    PubMed     Abstract available
    
    
    November 2016
52. ZHANG ZN, Zhang JS, Xiang J, Yu ZH, et al
    Subcutaneous rotenone rat model of Parkinson's disease: dose exploration study.
    Brain Res. 2016 Nov 19. pii: S0006-8993(16)30776.
    PubMed     Abstract available
    
    
    
53. DENG Q, Zhou X, Chen J, Pan M, et al
    Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.
    Brain Res. 2016 Nov 10. pii: S0006-8993(16)30744.
    PubMed     Abstract available
    
    
    
54. JANG Y, Koo JH, Kwon I, Kang EB, et al
    Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice.
    Brain Res. 2016 Nov 3. pii: S0006-8993(16)30740.
    PubMed     Abstract available
    
    
    September 2016
55. FARRAND AQ, Gregory RA, Backman CM, Helke KL, et al
    Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease.
    Brain Res. 2016 Sep 19. pii: S0006-8993(16)30653.
    PubMed     Abstract available
    
    
    
56. LIU KC, Li JY, Xie W, Li LB, et al
    Activation and blockade of serotonin6 receptors in the dorsal hippocampus enhance T maze and hole-board performance in a unilateral 6-hydroxydopamine rat model of Parkinson's disease.
    Brain Res. 2016 Sep 8. pii: S0006-8993(16)30617.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: